Volume surge · INSM · Healthcare

Insmed Inc (INSM) posts 33.0% weekly gain with turnover at 2.4x

The biotechnology stock’s 52-week weekly chart shows a sharp advance, but trend confirmation and relative-strength readings remain mixed.

Insmed Inc
Latest131.10 USD
1W move33.0%
Volume1.6x
TrendInactive
Biotechnology lab and market-data screen representing Insmed weekly stock activity.

Market update

What happened

Insmed Inc (INSM) closed the week at 131.10 USD, up 33.0% for the week, with the active-mover screen showing volume at 2.4x normal. The move lifted the stock’s four-week return to 13.4% and its twelve-week return to 20.1%.

Confirmation is not uniform. The trend signal is inactive, Market Dynamics show mild pressure at -0.07, and Relative Strength stands at -22.2, leaving the weekly context stronger on price and volume than on technical breadth.

The 52-week weekly price path frames the move as a biotechnology advance in a Healthcare name with a market value of about $23.1 billion.

Continue your research

Explore INSM across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

INSM coverage

Evidence context